Multi-Client Studies

Our Multi-Client Studies are in-depth studies of key subjects.

Tier 4 Company Profiles, Rank 21-50 (Oct 2015):  profiles animal health companies ranked 21-50, which are likely to be key participants in future industry consolidation, namely:

Agri Laboratories, aniMedica, Biogénesis Bagó, Biovet, Bioveta, Calier, Chanelle, CP Pokphand, ECO, Ecuphar, Fatro, Guangdong DaHuaNong, Harbin Pharmaceutical, IDT Biologika, Jinhe, KRKA, Kyoritsu Seiyaku, Kyoto Biken, Meiji Seika, Norbrook, Orion Pharma, Pharmaq, Pulike Biological, Putney, Qilu Pharmaceutical, Qingdao YeBio, Ringpu (Tianjin), Vallée, Xinjiang Tecon Animal Husbandry, Zhejiang Shenghua Biok Biology.

Top 60 Active Pharmaceutical Ingredient(s)/Top 100 Global Brands (March 2013): a unique analysis of the Top 60 franchises and products by active pharmaceutical ingredient(s), Top 50 global brand franchises and Top 100 global brands and loss of exclusivity in animal health.